GSK planning to reduce US sales force
UK drug major GSK is cutting approximately 1,000 US sales jobs by the end of 2008 as it reorganizes to compete in the increasingly tough pharmaceutical market.
Archives for November 5, 2008
Systech gears up for ePedigree ahead of time
Delays to US ePedigree and serialization laws, which will now not be implemented until 2015, could provide an unexpected windfall for US software firm Systech International and its PES platform.
Upfront targets CMOs with new MabDirect column
The new MabDirect MM Fixed D column, launched by Denmark’s Upfront Chromatography, could be a boon for CMO’s and pilot plants working in the expanding bio-processing sector.
What Obama means for pharma
Following Barack Obama’s victory in the race to the White House, in-PharmaTechnologist.com examines what this could mean for the pharmaceutical industry.
EFCG talks excipient certification
Tim Bölke, head of the excipient taskforce at the European Fine Chemicals Group, discusses certification and the heparin scandal.
RCP unveils new UK base and EU plans
RCP Therapeutics, a developer of regenerative medicine, hopes that its new HQ in the UK will benefit from the country’s status as a financial centre and proximity to cost effective trial sites in Eastern Europe.